Rivaroxaban versus enoxaparin after total knee arthroplasty.
Raju
Nina Chetty
NC
Dimmitt
Simon
S
Eikelboom
John W
JW
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000008:administration & dosage*; D005060:Europe; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D009656:North America; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban